Two different types of Excedrin headache medicine have been temporarily pulled from shelves by GlaxoSmithKline. The drug company has discontinued the production of Excedrin Extra Strength and Excedrin Migraine caplets and geltabs.
Quality Control Inconsistencies
A spokesperson for GlaxoSmithKline said: “Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs.”
Thankfully, there are no reported consumer issues with the products containing too much or too little of the active ingredients. The company pulled products from the shelves as a safety precaution.
“We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume,” reps from GSK said.
“Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product.”
Marketed as a popular headache and migraine remedy, Excedrin is a combo of acetaminophen (e.g., Tylenol), aspirin, and caffeine. The caffeine helps dilate blood vessels, which can alleviate symptoms of a severe headache.
GSK urges regular Excedrin users to talk to their doctor about finding the “most suitable alternative product” while they work on getting the product back on shelves. However, many migraine sufferers have taken to social media to express their dismay over the shortage.
Ask if your local drugstore offers a generic version of Excedrin. If they don’t carry one–or it’s already sold out–then you may need to grab a cup of coffee and a couple of aspirin the next time a headache strikes.
You can also try to prevent headaches by managing stress, watching your diet and getting enough sleep. And ironically, reducing your caffeine intake can actually help prevent headaches in the long run.